Two-dose COVID-19 vaccination regimens do not elicit adequate neutralising antibodies against the Omicron coronavirus variant, according to British researchers, implying that higher infections in persons who have been infected or vaccinated are expected. On Monday, researchers from the University of Oxford revealed the findings of an unpublished investigation in which they analysed blood samples from participants in a big trial who were given dosages from AstraZeneca-Oxford or Pfizer-BioNTech.
The findings came only one day after British Prime Minister Boris Johnson warned that two vaccination doses would not be enough to prevent the Omicron form from spreading.
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…